Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAPENTADOL vs TARLATAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TAPENTADOL vs TARLATAMAB: Safety Overview

Metric TAPENTADOL TARLATAMAB
Total FAERS Reports 29,208 145
Deaths Reported 20,205 49
Death Rate 69.2% 33.8%
Hospitalizations 3,304 52
Average Patient Age 58.0 yrs 62.7 yrs
% Female Patients 60.1% 34.0%
FDA Approval Date Aug 25, 2011 N/A
Manufacturer Collegium Pharmaceutical, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A